Triamcinolone acetonide-induced ocular hypertension

Journal of Ocular Pharmacology and Therapeutics

Volumn 22, Issue 4, 2006, Pages 247-250

  Jonas, Jost B ^a,b   Sauder, Gangolf ^a   Budde, Wido M ^a   Spandau, Ulrich H M ^a   Kamppeter, Bernd A ^a   Harder, Bjoern ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRIMONIDINE; CARBONATE DEHYDRATASE INHIBITOR; PREDNISOLONE; PROSTAGLANDIN DERIVATIVE; TRIAMCINOLONE ACETONIDE; ANTIHYPERTENSIVE AGENT; DIAGNOSTIC AGENT; GLUCOCORTICOID;

ADULT; ARTICLE; CASE REPORT; CONFOCAL SCANNING LASER TOMOGRAPHY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; OCULOPLETHYSMOGRAPHY; OPHTHALMOSCOPY; OPTIC DISK; PERIMETRY; PHOTOGRAPHY; POLARIMETRY; RETINA NEUROEPITHELIAL LAYER; SCANNING LASER POLARIMETRY; TOMOGRAPHY; UVEITIS; VISUAL ACUITY; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; LASER; NERVE FIBER; OPTIC NERVE DISEASE; PATHOLOGY; VISUAL SYSTEM EXAMINATION;

ADULT; ANTIHYPERTENSIVE AGENTS; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; FEMALE; GLUCOCORTICOIDS; HUMANS; INTRAOCULAR PRESSURE; LASERS; NERVE FIBERS; OCULAR HYPERTENSION; OPTIC DISK; OPTIC NERVE DISEASES; TOMOGRAPHY; TRIAMCINOLONE ACETONIDE; UVEITIS;

EID: 33749138889     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2006.22.247     Document Type: Article

References (5)

1. Machemer, R., Sugita, G., and Tano, Y. Treatment of intraocular proliferations with intravitreal steroids. Trans. Am. Ophthalmol. Soc. 77:171-180, 1979.
2. Danis, R.P., Ciulla, T.A., Pratt, L.M., et al. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 20:244-250, 2000.
3. Martidis, A., Duker, J.S., Greenberg, P.B., et al. Intravitreal triamcinolone for refractory diabetic macular oedema. Ophthalmology 109:920-927, 2002.
4. Gillies, M.C., Simpson, J.M., Luo, W, et al. A randomized, clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: One-year results. Arch. Ophthalmol. 121:667-673, 2003.
5. Jonas, J.B., Degenring, R.F., Kreissig, I., et al. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Ophthalmology 112:593-598, 2005.